Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Maintenance plasma exchange therapy for steroid-refractory neuromyelitis optica.
Roche and Biogen Idec decide to suspend Ocrelizumab treatment - Rheumatoid Arthritis development programme on hold
LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis.
Histologie de la sclerose en plaques
FDA Warns About CCSVI Treatment
Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D.
Rapidly progressive cerebellar ataxia in West Wales.
New therapies in the management of rheumatoid arthritis.
A network meta-analysis of randomized controlled trials for comparing the effectiveness and safety profile of treatments with marketing authorization for relapsing multiple sclerosis.
Episode 51 with Dr. Luke Lairson on discovery of small molecules to induce remyelination
Unusual association of Arnold-Chiari malformation and vitamin B12 deficiency.
MS Research Roundup: January 9, 2014
Epitope spreading as an early pathogenic event in pediatric multiple sclerosis.
MS Research Roundup: April 23, 2014
Efficacy and safety of BG-12 (dimethyl fumarate) and other disease modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison.
MS Patient, Ph.D.: Setting the Right Expectations for Recovery
Improper Inducements
Multiple sclerosis and pregnancy: experience from a nationwide database in Germany.
Ocrelizumab, a humanized anti-CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a phase I/II randomized, blinded, placebo-controlled, dose-ranging study.
Episode 71 with Dr. Brian Weinshenker on innovative clinical trials for NMO
MS Research Roundup: February 5, 2014
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial.
CSF Metabolite Analysis May Offer Sensitive Biomarkers for MS
A Study of Efficacy and Safety of Ocrelizumab in Patients with Relapse-Remitting Multiple Sclerosis
Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice.

Pages